Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-29 @ 2:54 PM
Study NCT ID:
NCT00224068
Status:
COMPLETED
Last Update Posted:
2012-03-02
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Sponsor:
Watson Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Iron deficiency | View |
| None | Sodium ferric gluconate | View |
| None | anemia | View |
| None | cancer chemotherapy | View |
| None | epoetin alfa | View |
| None | Anemia/drug therapy | View |
| None | Anemia, Iron-Deficiency/drug therapy/etiology | View |
| None | Hematinics/administration & dosage/pharmacology | View |
| None | Antineoplastic Agents/adverse effects | View |
| None | Erythropoietin, Recombinant/therapeutic use/adverse effects | View |